Impact Of Agitation Associated With Dementia Due To Alzheimer’s Disease In Marginalized Communities
Caring for an individual with agitation associated with dementia due to Alzheimer’s disease can also pose special challenges. Read More
- About
- PsychU For You
- Topics
- Events
- Content
Alzheimer’s Dementia
Alzheimer’s Care Disparities In Marginalized Communities
Marginalized communities experience challenges stemming from cultural differences, stigma, and gaps in care. Read MoreUnmet Needs in Agitation Associated with Dementia Due to Alzheimer’s Disease
This evidence-based review highlights important aspects of agitation associated with Alzheimer’s Dementia (AAD) for better understanding of the prevalence and challenges in diagnosis and explore the potential pathobiological correlations in… Read MoreVirtual Event – Pathophysiology of Agitation Associated with Dementia Due to Alzheimer’s Disease – The Potential Role Of The Norepinephrine, Serotonin & Dopamine (NSD) Neurotransmitter Systems
In this presentation, topics of discussion are: Loss of behavior regulation in agitation associated with AD; Monoamine systems in agitation associated with AD pathophysiology. Read MoreIdentifying Challenges & Navigating Treatment Landscape for Management of Agitation Associated with Dementia Due to Alzheimer’s Disease
Join us for a discussion with Dr. Douglas McLaughlin, as he provides perspective on identifying challenges and navigating the treatment landscape for management of agitation associated with dementia due to Alzheimer’s… Read MoreVirtual Event – Pathophysiology Of Agitation Associated With Alzheimer’s Dementia (AD) – The Potential Role Of The Norepinephrine, Serotonin & Dopamine (NSD) Neurotransmitter Systems
Lea Grinberg, MD, PhD is a speaker for Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) Shafa Shah, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) Read MoreUnmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)
This evidence-based review highlights important aspects of agitation associated with Alzheimer’s Dementia (AAD) for better understanding of the prevalence and challenges in diagnosis and explore the potential pathobiological correlations in AAD. Read MoreUnmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)
This evidence-based review highlights important aspects of agitation associated with Alzheimer’s Dementia (AAD) for better understanding of the prevalence and challenges in diagnosis and explore the potential pathobiological correlations in… Read MoreIdentifying Challenges & Navigating Treatment Landscape for Management of Agitation Associated with Dementia Due to Alzheimer’s Disease
Join us for a discussion with Dr. Douglas McLaughlin, as he provides perspective on identifying challenges and navigating the treatment landscape for management of agitation associated with dementia due to… Read MoreVirtual Event – Addressing Caregiver Burden & Identifying Agitation in Alzheimer’s Dementia
This presentation is intended to highlight the impact of caregiver burden, which includes a discussion on the challenges in recognizing agitation in Alzheimer’s dementia (AAD) and a review of helpful… Read More - PsychU For You
